Skip to main content

Robert Ward counsels start-up companies, venture capital firms, and global technology leaders on intellectual property (IP) and technology related matters. He focuses on medical device and digital health technology fields, including artificial intelligence (AI) and machine learning, as well as various other mechanical, electrical, and software based technologies, advising clients on strategic patent counseling, IP due diligence, and technology transactions.

Leveraging his engineering background, Robert works closely with clients to identify and protect core aspects of their technology. He counsels clients on global patent portfolio procurement and management with an emphasis in developing robust portfolios and IP strategies for emerging companies. Serving as outside IP counsel, he routinely prepares freedom-to-operate, invalidity, and patentability opinions. Robert also assists with all IP related aspects of mergers and acquisitions and has guided numerous medical device and health care start-up companies through exits.

In addition to intellectual property procurement and development, Robert prepares and negotiates agreements involving intellectual property and related corporate transactions including licensing, acquisition, development, services, consulting, confidentiality, and other agreements. He also has experience in intellectual property litigation before courts and the USPTO.

Concentrations

  • Patent portfolio management and strategic counseling
  • IP due diligence for venture capital firms and companies
  • MedTech—medical devices, digital health, artificial intelligence (AI)
  • Intellectual property and technology transactions
  • Litigation and pre-litigation strategy

Competenze

Esperienze Professionali - Attività Accademiche

  • Represented Gyrus Capital (Geneva, Switzerland) in the purchase of the heart valve business from LivaNova.°
  • Represented Cardiologs (acquired by Philips) on machine learning and artificial intelligence software for analyzing electrocardiogram (ECG) signals from a patient’s heart.°
  • Represented ReCor Medical (acquired by Otsuka) on renal denervation for the treatment of hypertension.°
  • Advised a global Fortune 50 publicly traded technology company on data privacy, intellectual property, competition, and other legal matters related to the development and launch of a virtual reality platform and launch of a virtual reality platform and features.°

°The above representations were handled by Mr. Ward prior to his joining Greenberg Traurig, LLP.

Riconoscimenti e Premi

  • Member, Board of Directors, Orange County Intellectual Property Law Association (OCIPLA), 2024-Present

Formazione

Formazione
  • Laurea magistrale in Giurisprudenza, Notre Dame Law School
  • M.S., Mechanical Engineering, Loyola Marymount University
  • B.S., Mechanical Engineering, University of Southern California
Abilitazioni
  • California
  • U.S. Patent and Trademark Office

Related Capabilities

Proprietà Intellettuale & Information Technology Patents and Innovation Strategies Life Sciences & Medical Technology Venture Capital & Emerging Technology Innovation & Artificial Intelligence